bis

White Biotechnology Market is Set to Reach $672.92 Billion by 2033

04 Sep 2025


?What is White Biotechnology and Why Does It Matter?

White biotechnology (industrial biotechnology) utilizes biological processes, microorganisms, and enzymes to produce industrial goods, biofuels, chemicals, and materials in a sustainable, eco-friendly way. It replaces traditional petrochemical manufacturing, reduces greenhouse gas emissions, and offers safer, non-toxic ingredients for sectors like pharmaceuticals, food, cosmetics, agriculture, and energy.

This market is critical as industries worldwide aim to lower their carbon footprints, meet regulatory requirements, and satisfy consumer demand for sustainable products. White biotechnology plays a vital role in transitioning major industries toward a circular, low-waste, and greener economy.

According to BIS Research, the global white biotechnology market was valued at $317.21 billion in 2024 and is expected to reach $672.92 billion by 2033, growing at a CAGR of 7.97% during the forecast period.

What’s Driving Growth in the White Biotechnology Market?

Key Drivers:

•    Sustainability Mandates: Global focus on eco-friendly, low-carbon production and greener supply chains.
•    Rising Demand for High-Purity Bioproducts: Especially in pharmaceuticals, food, and cosmetics.
•    Government & Regulatory Support: Policies and incentives favoring renewable chemicals and bio-based products.
•    Innovation in Bioengineering: Advances in genetic engineering, enzyme technology, and fermentation processes are enabling higher yields and new applications.
•    Growing Industrial Applications: Use across pharmaceuticals, agriculture, energy, food processing, and materials science.

Explore the Full TOC and Download Report Sample


What Are the Challenges in the White Biotechnology Market?

Key Challenges:

•    High Initial R&D and Capital Costs: Advanced biotechnology infrastructure requires significant investment.
•    Scale-Up and Commercialization Risks: Moving from lab-scale to industrial production presents technical and economic hurdles.
•    Regulatory Hurdles: Approval processes for bio-based products can be time-consuming and complex.
•    Competition with Conventional Technologies: Petrochemical alternatives may still be cheaper in some markets.

Market Segmentation: Where Are Growth Opportunities?

by Application
•    Bioenergy
•    Food and Feed Additives
•    Pharmaceutical Ingredients
•    Personal Care and Household Products
•    Others
by Product Type
•    Biochemical
•    Biofuel
•    Biomaterial
•    Bioproduct
by Region
•    North America - U.S., Canada, and Mexico
•    Europe - Germany, France, Italy, Spain, U.K., and Rest-of-Europe
•    Asia-Pacific - China, Japan, South Korea, India, and Rest-of-Asia-Pacific
•    Rest-of-the-World - South America and Middle East and Africa

[Download Sample Report]


Analyst Perspective: What’s Next for White Biotechnology?

The white biotechnology market is poised for robust growth, driven by global sustainability agendas, technological advancements, and expanding industrial adoption. As regulations tighten and consumers prioritize greener choices, companies that innovate with new bioproducts and scale up sustainable production will see the greatest benefits. Investment in R&D, partnerships, and regulatory navigation are key success factors in this evolving landscape.

– BIS Research Analyst Team

FAQs About the White Biotechnology Market

What is the expected growth rate of the white biotechnology market?

The market is projected to grow at a CAGR of 7.97% from 2025–2033.

Who are the key leaders in the white biotechnology market?

Major players include Medtronic, Novozymes, BASF SE, DuPont, Cargill, Inc, Royal DSM N.V, Archer Daniles Midland Company, BioAmber Inc, Lesaffre, Corbion N.V, Evonik Industries AG, Genomatica, Inc, Ginkgo Bioworks, Amyris Inc, TerraVia Holdings, Inc

Which technologies and products are most in demand?

Bio-based chemicals, advanced enzymes, fermentation technology, and bioplastics are in high demand, driven by industrial, pharmaceutical, and consumer goods applications.

Want to Make Data-Backed Moves in White Biotechnology?

BIS Research offers KOL-based insights, rigorous segmentation, and strategic advisory across software, hardware, and sensing tech domains. 

 [Contact Analyst]
 [Download TOC]